48 related articles for article (PubMed ID: 33407486)
1. Identification of a Prognostic Colorectal Cancer Model Including LncRNA FOXP4-AS1 and LncRNA BBOX1-AS1 Based on Bioinformatics Analysis.
Shi ZL; Zhou GQ; Guo J; Yang XL; Yu C; Shen CL; Zhu XG
Cancer Biother Radiopharm; 2022 Dec; 37(10):893-906. PubMed ID: 33481661
[No Abstract] [Full Text] [Related]
2. Perspectives of ERCC1 in early-stage and advanced cervical cancer: From experiments to clinical applications.
Du P; Li G; Wu L; Huang M
Front Immunol; 2022; 13():1065379. PubMed ID: 36713431
[TBL] [Abstract][Full Text] [Related]
3. Interstrand crosslink repair: can XPF-ERCC1 be let off the hook?
Bergstralh DT; Sekelsky J
Trends Genet; 2008 Feb; 24(2):70-6. PubMed ID: 18192062
[TBL] [Abstract][Full Text] [Related]
4. XPF expression and its relationship with the risk and prognosis of colorectal cancer.
Hu H; Jing J; Lu X; Yuan Y; Xing C
Cancer Cell Int; 2021 Jan; 21(1):12. PubMed ID: 33407486
[TBL] [Abstract][Full Text] [Related]
5. DNA repair protein XPA is differentially expressed in colorectal cancer and predicts better prognosis.
Feng X; Liu J; Gong Y; Gou K; Yang H; Yuan Y; Xing C
Cancer Med; 2018 Jun; 7(6):2339-2349. PubMed ID: 29675892
[TBL] [Abstract][Full Text] [Related]
6. Correlation of xeroderma pigmentosum complementation group F expression with gastric cancer and prognosis.
Li P; Ma Y
Oncol Lett; 2018 Dec; 16(6):6971-6976. PubMed ID: 30546430
[TBL] [Abstract][Full Text] [Related]
7. Expression of DDB2 Protein in the Initiation, Progression, and Prognosis of Colorectal Cancer.
Yang H; Liu J; Jing J; Wang Z; Li Y; Gou K; Feng X; Yuan Y; Xing C
Dig Dis Sci; 2018 Nov; 63(11):2959-2968. PubMed ID: 30054844
[TBL] [Abstract][Full Text] [Related]
8. The age-related expression decline of ERCC1 and XPF for forensic age estimation: A preliminary study.
Deng XD; Gao Q; Zhang W; Zhang B; Ma Y; Zhang LX; Muer C; Xie Y; Liu Y
J Forensic Leg Med; 2017 Jul; 49():15-19. PubMed ID: 28486142
[TBL] [Abstract][Full Text] [Related]
9. Xeroderma pigmentosum complementation group C single-nucleotide polymorphisms in the nucleotide excision repair pathway correlate with prolonged progression-free survival in advanced ovarian cancer.
Fleming ND; Agadjanian H; Nassanian H; Miller CW; Orsulic S; Karlan BY; Walsh CS
Cancer; 2012 Feb; 118(3):689-97. PubMed ID: 21751198
[TBL] [Abstract][Full Text] [Related]
10. Expression and Clinical Significance of ERCC1 and XPF in Human Hepatocellular Carcinoma.
Liao X; Li Y; Li H; Huang W; Wang H; Xie W
Onco Targets Ther; 2020; 13():1059-1072. PubMed ID: 32099408
[TBL] [Abstract][Full Text] [Related]
11. Association between nucleotide excision repair gene polymorphism and colorectal cancer risk.
Zhang Y; Wu S; Zhou X; Huang F; Chen R; Wang Y; Wu J
J Clin Lab Anal; 2019 Oct; 33(8):e22956. PubMed ID: 31568607
[TBL] [Abstract][Full Text] [Related]
12. Tre2 (USP6NL) promotes colorectal cancer cell proliferation via Wnt/β-catenin pathway.
Sun K; He SB; Yao YZ; Qu JG; Xie R; Ma YQ; Zong MH; Chen JX
Cancer Cell Int; 2019; 19():102. PubMed ID: 31015802
[TBL] [Abstract][Full Text] [Related]
13. ERCC1-XPF deficiency is a predictor of olaparib induced synthetic lethality and platinum sensitivity in epithelial ovarian cancers.
Mesquita KA; Alabdullah M; Griffin M; Toss MS; Fatah TMAA; Alblihy A; Moseley P; Chan SYT; Rakha EA; Madhusudan S
Gynecol Oncol; 2019 May; 153(2):416-424. PubMed ID: 30797591
[TBL] [Abstract][Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
